View in EDS

Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.

Saved in:
Bibliographic Details
Title: Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.
Authors: Wang L; aShanghai Pulmonary Hospital, Tongji University of School of Medicine, Shanghai, China., Yao W; bSichuan Cancer Hospital, Chengdu, China., Shen H; cThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Xie C; dZhongnan Hospital of Wuhan University, Wuhan, China., Chen H; eAffiliated Hospital of Guangdong Medical University, Zhanjiang, China., Chen K; fThe First Affiliated Hospital of Soochow University, Suzhou, China., Su W; gShanxi Cancer Hospital, Taiyuan, China., Gan X; hThe First Affiliated Hospital of Nanchang University, Nanchang, China., Zhuo M; iBeijing Cancer Hospital, Beijing, China., Chen E; jShaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, China., Xu Z; kThe Second Affiliated Hospital of PLA Army Medical University, Chongqing, China., Zhang Y; lShijiazhuang People's Hospital (Jianhua Hospital), Shijiazhuang, China., Wang M; mPeking Union Medical College Hospital, Beijing, China., Ma R; nLiaoning Cancer Hospital, Shenyang, China., Wu H; oNingbo Medical Center Li Huili Hospital, Ningbo, China., Zhang Z; pAnhui Provincial Cancer Hospital, Hefei, China., Ye F; qThe First Affiliated Hospital of Xiamen University, Xiamen, China., Moore AC; rSummit Therapeutics, Menlo Park, CA, USA., Zhou C; aShanghai Pulmonary Hospital, Tongji University of School of Medicine, Shanghai, China.; sShanghai East Hospital, Shanghai, China.
Source: Future oncology (London, England) [Future Oncol] 2026 Jan; Vol. 22 (1), pp. 27-36. Date of Electronic Publication: 2025 Dec 28.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41457351
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; aShanghai Pulmonary Hospital, Tongji University of School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yao+W%22">Yao W</searchLink>; bSichuan Cancer Hospital, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Shen+H%22">Shen H</searchLink>; cThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Xie+C%22">Xie C</searchLink>; dZhongnan Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; eAffiliated Hospital of Guangdong Medical University, Zhanjiang, China.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; fThe First Affiliated Hospital of Soochow University, Suzhou, China.<br /><searchLink fieldCode="AU" term="%22Su+W%22">Su W</searchLink>; gShanxi Cancer Hospital, Taiyuan, China.<br /><searchLink fieldCode="AU" term="%22Gan+X%22">Gan X</searchLink>; hThe First Affiliated Hospital of Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Zhuo+M%22">Zhuo M</searchLink>; iBeijing Cancer Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Chen+E%22">Chen E</searchLink>; jShaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Xu+Z%22">Xu Z</searchLink>; kThe Second Affiliated Hospital of PLA Army Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; lShijiazhuang People's Hospital (Jianhua Hospital), Shijiazhuang, China.<br /><searchLink fieldCode="AU" term="%22Wang+M%22">Wang M</searchLink>; mPeking Union Medical College Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Ma+R%22">Ma R</searchLink>; nLiaoning Cancer Hospital, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; oNingbo Medical Center Li Huili Hospital, Ningbo, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; pAnhui Provincial Cancer Hospital, Hefei, China.<br /><searchLink fieldCode="AU" term="%22Ye+F%22">Ye F</searchLink>; qThe First Affiliated Hospital of Xiamen University, Xiamen, China.<br /><searchLink fieldCode="AU" term="%22Moore+AC%22">Moore AC</searchLink>; rSummit Therapeutics, Menlo Park, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+C%22">Zhou C</searchLink>; aShanghai Pulmonary Hospital, Tongji University of School of Medicine, Shanghai, China.; sShanghai East Hospital, Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2026 Jan; Vol. 22 (1), pp. 27-36. <i>Date of Electronic Publication: </i>2025 Dec 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41457351
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2025.2601138
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 27
    Titles:
      – TitleFull: Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Yao W
      – PersonEntity:
          Name:
            NameFull: Shen H
      – PersonEntity:
          Name:
            NameFull: Xie C
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Su W
      – PersonEntity:
          Name:
            NameFull: Gan X
      – PersonEntity:
          Name:
            NameFull: Zhuo M
      – PersonEntity:
          Name:
            NameFull: Chen E
      – PersonEntity:
          Name:
            NameFull: Xu Z
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Wang M
      – PersonEntity:
          Name:
            NameFull: Ma R
      – PersonEntity:
          Name:
            NameFull: Wu H
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Ye F
      – PersonEntity:
          Name:
            NameFull: Moore AC
      – PersonEntity:
          Name:
            NameFull: Zhou C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1